Edward B Neufeld is a prominent inventor based in Washington, DC (US). He has made significant contributions to the field of peptide technology, holding a total of 4 patents. His work focuses on developing innovative methods for treating dyslipidemic disorders and inflammation.

Latest Patents

Neufeld's latest patents include groundbreaking research on multi-domain amphipathic helical peptides. These peptides or peptide analogs possess multiple amphipathic α-helical domains that promote lipid efflux from cells via an ABCA1-dependent pathway. His patents also disclose methods for using these peptides to treat or inhibit dyslipidemic disorders. Additionally, he has developed methods for identifying non-cytotoxic peptides that promote ABCA1-dependent lipid efflux from cells.

Career Highlights

Neufeld is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been instrumental in advancing the understanding of peptide applications in medical treatments.

Collaborations

He has collaborated with notable colleagues, including Alan Thomas Remaley and Stephen J Demosky, to further enhance the impact of his research.

Conclusion

Edward B Neufeld's innovative work in peptide technology continues to pave the way for new treatments in the medical field. His contributions are vital for addressing complex health issues related to lipid metabolism and inflammation.

This text is generated by artificial intelligence and may not be accurate.